|
Index of reports
> Life Threatening Events (6)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Catapres (Clonidine) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Catapres side effects in 38 year old male
Reported by a pharmacist from United States on 2012-07-12
Patient: 38 year old male, weighing 105.3 kg (231.7 pounds)
Reactions: Cervical Vertebral Fracture, Road Traffic Accident, Pruritus, NO Therapeutic Response, Rash Maculo-Papular, Craniocerebral Injury
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Catapres
Other drugs received by patient: Acetaminophen; Albuterol; Cholecalciferol; Magnesium Hydroxide / Aluminum Hydroxide / Simethicone
Possible Catapres side effects in 38 year old male
Reported by a pharmacist from United States on 2012-07-12
Patient: 38 year old male, weighing 105.3 kg (231.7 pounds)
Reactions: Pruritus, Drug Ineffective, Rash Maculo-Papular
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Catapres
Other drugs received by patient: ICY HOT; Albuterol Nebulizer Soln; Cholecalciferol; Fentanyl; Paroxetine; Acetaminophen; Simethicone; Trazodone Hydrochloride; Diazepam Rectal Gel; Multi-Vitamin; Ondansetron; Zolpidem; Midodrine Hydrochloride; Magnesium Hydroxide / Aluminum Hydroxide / Simethicone; Melatonin; Miconazole; Quetiapine
Possible Catapres side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-22
Patient: female, weighing 65.4 kg (143.9 pounds)
Reactions: Blood Pressure Increased, Dyspnoea, Labile Hypertension, Drug Ineffective, Urinary Incontinence, Blood Potassium Increased, Headache, Hypertensive Crisis, Overdose, Bronchitis, Cough, Atrioventricular Block First Degree
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Labetalol
Dosage: 1 df, qid
Levothroid
Dosage: 600 ug, unk
Administration route: Oral
Levothroid
Dosage: 300 ug, unk
Administration route: Oral
Gilenya
Dosage: 0.5 mg, qd
Administration route: Oral
Indication: Multiple Sclerosis
Start date: 2011-06-06
End date: 2011-11-04
Labetalol
Dosage: 1 df, q6h
Administration route: Oral
Catapres
Dosage: 0.1 mg, tid (prn)
Administration route: Oral
Zestril
Dosage: 10 mg, bid
Labetalol
Dosage: 900 mg, once/single
Administration route: Oral
Lopressor
Dosage: 50 mg, tid
Administration route: Oral
Catapres
Dosage: 0.1 mg, tid (prn)
Administration route: Oral
Cardizem LA
Dosage: unk ukn, unk
Indication: Coronary Artery Disease
Other drugs received by patient: Synthroid; Aldactone; Amitiza; Clonidine; Aldactone; Prozac; Prilosec; Vitamin D; Valium; Dyazide; Valium
Possible Catapres side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-22
Patient: female, weighing 65.4 kg (143.9 pounds)
Reactions: Blood Pressure Increased, Dyspnoea, Labile Hypertension, Drug Ineffective, Urinary Incontinence, Blood Potassium Increased, Headache, Hypertensive Crisis, Overdose, Bronchitis, Cough, Atrioventricular Block First Degree
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Levothroid
Dosage: 300 ug, unk
Administration route: Oral
Levothroid
Dosage: 600 ug, unk
Administration route: Oral
Catapres
Dosage: 0.1 mg, tid (prn)
Administration route: Oral
Labetalol HCL
Dosage: 1 df, q6h
Administration route: Oral
Catapres
Dosage: 0.1 mg, tid (prn)
Administration route: Oral
Labetalol HCL
Dosage: 1 df, qid
Gilenya
Dosage: 0.5 mg, qd
Administration route: Oral
Indication: Multiple Sclerosis
Start date: 2011-06-06
End date: 2011-11-04
Lopressor
Dosage: 50 mg, tid
Administration route: Oral
Cardizem LA
Dosage: unk ukn, unk
Indication: Coronary Artery Disease
Labetalol HCL
Dosage: 900 mg, once/single
Administration route: Oral
Zestril
Dosage: 10 mg, bid
Other drugs received by patient: Prozac; Vitamin D; Synthroid; Aldactone; Valium; Valium; Prilosec; Clonidine; Aldactone; Dyazide; Amitiza
Possible Catapres side effects in female
Reported by a consumer/non-health professional from United States on 2012-01-09
Patient: female, weighing 65.4 kg (143.9 pounds)
Reactions: Blood Pressure Increased, Dyspnoea, Drug Ineffective, Labile Hypertension, Urinary Incontinence, Blood Potassium Increased, Headache, Hypertensive Crisis, Overdose, Bronchitis, Atrioventricular Block First Degree, Cough
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Labetalol HCL
Dosage: 1 df, qid
Lopressor
Dosage: 50 mg, tid
Administration route: Oral
Labetalol HCL
Dosage: 1 df, q6h
Administration route: Oral
Catapres
Dosage: 0.1 mg, tid (prn)
Administration route: Oral
Zestril
Dosage: 10 mg, bid
Levothroid
Dosage: 300 ug, unk
Administration route: Oral
Cardizem LA
Dosage: unk ukn, unk
Indication: Coronary Artery Disease
Gilenya
Dosage: 0.5 mg, qd
Administration route: Oral
Indication: Multiple Sclerosis
Start date: 2001-06-06
End date: 2011-11-04
Labetalol HCL
Dosage: 900 mg, once/single
Administration route: Oral
Catapres
Dosage: 0.1 mg, tid (prn)
Administration route: Oral
Gilenya
Indication: Demyelination
Levothroid
Dosage: 600 ug, unk
Administration route: Oral
Other drugs received by patient: Synthroid; Valium; Prilosec; Prozac; Aldactone; Amitiza; Valium; Aldactone; Dyazide; Clonidine; Vitamin D
Possible Catapres side effects in female
Reported by a physician from United States on 2012-01-09
Patient: female, weighing 65.4 kg (143.9 pounds)
Reactions: Blood Pressure Increased, Dyspnoea, Labile Hypertension, Drug Ineffective, Urinary Incontinence, Blood Potassium Increased, Headache, Hypertensive Crisis, Overdose, Bronchitis, Atrioventricular Block First Degree, Cough
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Lopressor
Dosage: 50 mg, tid
Administration route: Oral
Gilenya
Dosage: 0.5 mg, qd
Administration route: Oral
Indication: Multiple Sclerosis
Start date: 2001-06-06
End date: 2011-11-04
Levothroid
Dosage: 300 ug, unk
Administration route: Oral
Labetalol HCL
Dosage: 900 mg, once/single
Administration route: Oral
Labetalol HCL
Dosage: 1 df, qid
Gilenya
Indication: Demyelination
Labetalol HCL
Dosage: 1 df, q6h
Administration route: Oral
Cardizem LA
Dosage: unk ukn, unk
Indication: Coronary Artery Disease
Levothroid
Dosage: 600 ug, unk
Administration route: Oral
Catapres
Dosage: 0.1 mg, tid (prn)
Administration route: Oral
Zestril
Dosage: 10 mg, bid
Catapres
Dosage: 0.1 mg, tid (prn)
Administration route: Oral
Other drugs received by patient: Amitiza; Prozac; Dyazide; Clonidine; Vitamin D; Aldactone; Aldactone; Valium; Synthroid; Valium; Prilosec
|
